Adrian Minson

15PUBLICATIONS
48CO-AUTHORS
Haematological tumoursRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 07, 2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

|Apr 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphoma.

|Jun 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study.

Adrian Minson, Emma Verner, Pratyush Giri

|Mar 20, 2025
Enterocolitis associated with glofitamab-First report and clinicopathological findings in three cases.

Sean McKeague, Molly Robertson, Sam van der Linde

|May 09, 2024
Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high.

Samuel Grigg, Adrian Minson, Elizabeth Prins

|Oct 31, 2023
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.

Adrian Minson, Nada Hamad, Pietro Di Ciaccio

Pageof 3

Frequent Collaborators

8 joint publications

Michael J Dickinson

5 joint publications

John F Seymour

3 joint publications

Chan Y Cheah

3 joint publications

Nada Hamad